Data from Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti–PD-1 Refractory Melanoma
Authors:
- Cara HaymakerCHCara Haymaker
- Daniel H. JohnsonDJDaniel H. Johnson
- Ravi MurthyRMRavi Murthy
- Salah-Eddine BentebibelSBSalah-Eddine Bentebibel
- Marc I. UemuraMUMarc I. Uemura
- Courtney W. HudgensCHCourtney W. Hudgens
- Houssein SafaHSHoussein Safa
- Marihella JamesMJMarihella James
- Robert H.I. AndtbackaRARobert H.I. Andtbacka
- Douglas B. JohnsonDJDouglas B. Johnson
- Montaser ShaheenMSMontaser Shaheen
- Michael A. DaviesMDMichael A. Davies
Open Access
- 3 April 2023
- other
- Published by American Association for Cancer Research (AACR)